About
The National Institutes of Health (NIH) is the largest public funder of biomedical research in the world, investing most of its nearly $48 billion budget in medical research to enhance life and reduce illness and disability. It is the primary agency of the United States federal government responsible for biomedical and public health research, founded in 1887 and part of the U.S. Department of Health and Human Services (HHS). NIH conducts its scientific research through its Intramural Research Program (IRP) and provides significant biomedical research funding to non-NIH research facilities through its Extramural Research Program. NIH-funded research has led to breakthroughs and new treatments, contributing to increased life expectancy and driving discovery.
Portfolio
Investment activity
Portfolio by sector
Q&A
- What is the primary sector focus of National Institute of Health (NIH) investments?
- National Institute of Health (NIH) primarily focuses its investments in the Health Tech & Life Sciences sector, with one recorded investment in this area.
- Can you name a notable company in National Institute of Health (NIH)'s portfolio?
- A notable company in National Institute of Health (NIH)'s portfolio is Anima Biotech, which specializes in small-molecule mRNA drug discovery.
- What was the most recent investment activity by National Institute of Health (NIH)?
- National Institute of Health (NIH) made an investment in January 2018, which was also the month they added a new portfolio company.
- What type of funding did Anima Biotech receive from National Institute of Health (NIH)?
- Anima Biotech received Seed funding, raising $30M, with National Institute of Health (NIH) participating in the round.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 1887-8 |
|---|
Radar intelligence
Patents
| EPO | 26 |
|---|